Chan Yue Li
Director/Board Member chez TAIWAN LIPOSOME COMPANY, LTD.
Profil
Chan Yue Li currently works at Taiwan Liposome Co., Ltd., as Director from 2014, Steminent Biotherapeutics, Inc., as Director from 2021, and Lin BioScience, Inc., as Director from 2016.
Mr. Li also formerly worked at UBI Pharma Inc., as Director.
Mr. Li received his graduate degree from the University of Iowa.
Postes actifs de Chan Yue Li
| Sociétés | Poste | Début |
|---|---|---|
| TAIWAN LIPOSOME COMPANY, LTD. | Director/Board Member | 18/06/2014 |
| LIN BIOSCIENCE, INC. | Director/Board Member | 13/10/2016 |
| STEMINENT BIOTHERAPEUTICS, INC | Director/Board Member | 08/12/2021 |
Anciens postes connus de Chan Yue Li
| Sociétés | Poste | Fin |
|---|---|---|
| UBI PHARMA INC. | Director/Board Member | - |
Formation de Chan Yue Li
| University of Iowa | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| STEMINENT BIOTHERAPEUTICS, INC | Health Technology |
| UBI PHARMA INC. | Health Technology |
| LIN BIOSCIENCE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
